Mortality and disease severity among COVID-19 patients receiving renin-angiotensin system inhibitors: a systematic review and meta-analysis
Introduction The use of renin-angiotensin system (RAS) inhibitors, including angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), was …
converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), was …
Renin–angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies
Aims: We sought to evaluate the association of angiotensin-converting-enzyme inhibitors
(ACEI) or AT1 blockers (ARB) therapy with clinical outcomes in patients with coronavirus …
(ACEI) or AT1 blockers (ARB) therapy with clinical outcomes in patients with coronavirus …
Effects of renin–angiotensin system inhibitors on mortality and disease severity of COVID-19 patients: a meta-analysis of randomized controlled trials
J Yin, C Wang, X Song, X Li… - American Journal of …, 2022 - academic.oup.com
BACKGROUND There is controversy over the effects of angiotensin-converting enzyme
inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) on the prognosis in patients …
inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) on the prognosis in patients …
The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
Abstract Background and Aims; To investigate the association between use of angiotensin-
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …
Mortality and severity in COVID-19 patients on ACEIs and ARBs—a systematic review, meta-analysis, and meta-regression analysis
Purpose: The primary objective of this systematic review is to assess association of mortality
in COVID-19 patients on Angiotensin-converting-enzyme inhibitors (ACEIs) and Angiotensin …
in COVID-19 patients on Angiotensin-converting-enzyme inhibitors (ACEIs) and Angiotensin …
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis
Background The use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II
receptor blockers (ARB) in patients with coronavirus disease 2019 (COVID-19) given their …
receptor blockers (ARB) in patients with coronavirus disease 2019 (COVID-19) given their …
Renin-angiotensin system antagonists are associated with lower mortality in hypertensive patients with COVID-19
M Megaly, M Glogoza - Scottish Medical Journal, 2020 - journals.sagepub.com
The use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor
blockers (ARBs) in patients with Coronavirus 2019 (COVID-19) has been controversial. We …
blockers (ARBs) in patients with Coronavirus 2019 (COVID-19) has been controversial. We …
Impact of treatment with renin–angiotensin system inhibitors on clinical outcomes in hypertensive patients hospitalized with COVID-19
M Negreira-Caamaño, J Piqueras-Flores… - High Blood Pressure & …, 2020 - Springer
Introduction Concerns have been raised about the possible harmfulness of angiotensin-
converter enzyme inhibitors (ACEi) and aldosterone receptor blockers (ARB) in patients with …
converter enzyme inhibitors (ACEi) and aldosterone receptor blockers (ARB) in patients with …
[HTML][HTML] Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors in COVID-19: meta-analysis/meta-regression adjusted for confounding factors
Abstract Background Angiotensin receptor blockers (ARBs) and/or angiotensin-converting
enzyme (ACE) inhibitors could alter mortality from coronavirus disease 2019 (COVID-19) …
enzyme (ACE) inhibitors could alter mortality from coronavirus disease 2019 (COVID-19) …
Renin-angiotensin system inhibitors and COVID-19: a systematic review and meta-analysis. Evidence for significant geographical disparities
D Patoulias, A Katsimardou, K Stavropoulos… - Current hypertension …, 2020 - Springer
Abstract Purpose of Review While the COVID-19 pandemic is constantly evolving, it remains
unclear whether the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin …
unclear whether the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin …
相关搜索
- meta analysis covid 19
- renin angiotensin covid 19
- meta analysis renin angiotensin
- enzyme inhibitors covid 19
- hypertensive patients covid 19
- meta analysis enzyme inhibitors
- effects of renin disease severity
- renin angiotensin lower mortality
- meta analysis mortality and severity
- mortality in patients coronavirus disease
- lower mortality covid 19
- coronavirus disease covid 19
- renin angiotensin hypertensive patients
- meta analysis outcomes in patients
- meta analysis coronavirus disease
- enzyme inhibitors outcomes in patients